[Content of immunoreactive insulin in the plasma and insulin sensitivity in patients with diabetes mellitus during the process of sulfanilamide compensation of metabolic disorders].
D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood / Q000627:therapeutic use; D007330:Insulin Antibodies; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D007328:Insulin; D007330:Insulin Antibodies; D013453:Sulfonylurea Compounds
Soderzhanie immunoreaktivnogo insulina v plazme krovi i chuvstvitel'nost' k insulinu u bol'nykh sakharnym diabetom v protsesse kompensatsii narusheniĭ metabolizma sul'fanilamidnymi preparatami.